Nucleic Acids Research Advance Access published online on October 28, 2008
Nucleic Acids Research, doi:10.1093/nar/gkn823
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Database Issue |
APD2: the updated antimicrobial peptide database and its application in peptide design
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805, USA
*To whom correspondence should be addressed. Tel: +1 402 559 4176; Fax: +1 402 559 4651; Email: gwang{at}unmc.edu
Received October 10, 2008. Accepted October 13, 2008.
The antimicrobial peptide database (APD, http://aps.unmc.edu/AP/main.php) has been updated and expanded. It now hosts 1228 entries with 65 anticancer, 76 antiviral (53 anti-HIV), 327 antifungal and 944 antibacterial peptides. The second version of our database (APD2) allows users to search peptide families (e.g. bacteriocins, cyclotides, or defensins), peptide sources (e.g. fish, frogs or chicken), post-translationally modified peptides (e.g. amidation, oxidation, lipidation, glycosylation or D-amino acids), and peptide binding targets (e.g. membranes, proteins, DNA/RNA, LPS or sugars). Statistical analyses reveal that the frequently used amino acid residues (>10%) are Ala and Gly in bacterial peptides, Cys and Gly in plant peptides, Ala, Gly and Lys in insect peptides, and Leu, Ala, Gly and Lys in amphibian peptides. Using frequently occurring residues, we demonstrate database-aided peptide design in different ways. Among the three peptides designed, GLK-19 showed a higher activity against Escherichia coli than human LL-37.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. C. F. Oyston, M. A. Fox, S. J. Richards, and G. C. Clark Novel peptide therapeutics for treatment of infections J. Med. Microbiol., August 1, 2009; 58(8): 977 - 987. [Abstract] [Full Text] [PDF] |
||||
